Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1007 

    Article Cited by others

SYSTEMATIC REVIEW

Furazolidone-based therapies for Helicobacter pylori infection: A pooled-data analysis

Zullo Angelo, Ierardi Enzo, Hassan Cesare, De Francesco Vincenzo

Year : 2012| Volume: 18| Issue : 1 | Page no: 11-17

   This article has been cited by
 
1 Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology
Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Niranjan Rout, Philip Abraham, Prakash Chandra Dalai, Pravin Rathi, Saroj K. Sinha, Shobna Bhatia, Susama Patra, Ujjala Ghoshal, Ujjal Poddar, Venigalla Pratap Mouli, Vikram Kate
Indian Journal of Gastroenterology. 2021; 40(4): 420
[Pubmed]  [Google Scholar] [DOI]
2 Helicobacter pylori infection and antibiotic resistance ó from biology to clinical implications
Evariste Tshibangu-Kabamba, Yoshio Yamaoka
Nature Reviews Gastroenterology & Hepatology. 2021; 18(9): 613
[Pubmed]  [Google Scholar] [DOI]
3 Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, Iran
Farnaz Rasi-Bonab, Abolfazl Jafari-Sales, Mohammad Amin Shaverdi, Tahereh Navidifar, Morteza Saki, Atosa Ghorbani, Abimbola Olumide Adekanmbi, Behboud Jafari, Sara Naebi
BMC Research Notes. 2021; 14(1)
[Pubmed]  [Google Scholar] [DOI]
4 Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-Resistant H. pylori infection
Elena Resina, Javier P. Gisbert
Antibiotics. 2021; 10(9): 1028
[Pubmed]  [Google Scholar] [DOI]
5 Bi-functional catalytic performance of silver manganite/polypyrrole nanocomposite for electrocatalytic sensing and photocatalytic degradation
Manickavasagan Abinaya, Velluchamy Muthuraj
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020; 604: 125321
[Pubmed]  [Google Scholar] [DOI]
6 Concomitant and controlled release of furazolidone and bismuth(III) incorporated in a cross-linked sodium alginate-carboxymethyl cellulose hydrogel
KlŠudia Maria Machado Neves Silva, Diogo …merson Leite de Carvalho, V‚nia Maria Moreira Valente, Juan Carlos Campos Rubio, Paulo EustŠquio Faria, Priscila Pereira Silva-Caldeira
International Journal of Biological Macromolecules. 2019; 126: 359
[Pubmed]  [Google Scholar] [DOI]
7 Synthesis of thio- and furan-fused heterocycles: furopyranone, furopyrrolone, and thienopyrrolone derivatives
Merve Ergun,Cagatay Dengiz,Merve Sinem ÷zer,Ertan Sahin,Metin Balci
Tetrahedron. 2014;
[Pubmed]  [Google Scholar] [DOI]
8 Helicobacter pylori: Future perspectives in therapy reflecting three decades of experience
Kanizaj, T.F., Kunac, N.
World Journal of Gastroenterology. 2014; 20(3): 699-705
[Pubmed]  [Google Scholar]
9 Clinical Management ofHelicobacter pyloriInfection in China
Chuan Xie,Nong-Hua Lu
Helicobacter. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
10 How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?
Ierardi, E., Giorgio, F., Losurdo, G., Di Leo, A., Principi, M.
World Journal of Gastroenterology. 2013; 19(45): 8168-8180
[Pubmed]  [Google Scholar]
11 Eradikationstherapie bei Helicobacter-pylori-Infektionen: Die Leitlinien der II. Asiatisch-Pazifischen Konferenz und des IV. Maastricht/Florenz-konsensus-reports. Was kam danach? | [Eradication therapy in Helicobacter pylori infection: The guidelines of the second Asia-Pacific consensus conference and of the Maastricht IV/Florence report. What will be coming according to that?]
Bosseckert, H.
Verdauungskrankheiten. 2013; 31(5): 227-242
[Pubmed]  [Google Scholar]
12 a novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia
jiang, x. and sun, l. and qiu, j.j. and sun, x. and li, s. and wang, x. and so, c.w.e. and dong, s.
plos one. 2013; 8(8)
[Pubmed]  [Google Scholar]
13 3rd brazilian consensus on helicobacter pylori [3į consenso brasileiro para estudo do helicobacter pylori]
coelho, l.g. and maguinilk, i. and zaterka, s. and parente, j.m. and passos, m.c.f. and moraes-filho, j.p.p.
arquivos de gastroenterologia. 2013; 50(2): 1-17
[Pubmed]  [Google Scholar]
14 3rd Brazilian consensus on Helicobacter pylori [3¬į consenso Brasileiro para Estudo do Helicobacter pylori]
Coelho, L.G. and Maguinilk, I. and Zaterka, S. and Parente, J.M. and Passos, M.C.F. and Moraes-Filho, J.P.P.
Arquivos de Gastroenterologia. 2013; 50(2): 1-17
[Pubmed]  [Google Scholar]
15 Modified sequential therapy regimens for Helicobacter pylori eradication: A systematic review
Zullo, A. and De Francesco, V. and Hassan, C. and Ridola, L. and Repici, A. and Bruzzese, V. and Vaira, D.
Digestive and Liver Disease. 2013; 45(1): 18-22
[Pubmed]  [Google Scholar]
16 Treatment of Helicobacter pylori infection 2012
Tepes, B. and OśConnor, A. and Gisbert, J.P. and OśMorain, C.
Helicobacter. 2012; 17(SUPPL.1): 36-42
[Pubmed]  [Google Scholar]
17 Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations
C. Y. Tay,H. M. Windsor,F. Thirriot,W. Lu,C. Conway,T. T. Perkins,B. J. Marshall
Alimentary Pharmacology & Therapeutics. 2012; 36(11-12): 1076
[Pubmed]  [Google Scholar] [DOI]

 

Read this article